FHIR IG analytics
| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1116.602.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1116.602/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.602 |
| Version | 20240703 |
| Status | active |
| Date | 2024-07-03T01:06:58-04:00 |
| Name | Neurokinin1ReceptorAntagonist |
| Title | Neurokinin 1 Receptor Antagonist |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of medication for Neurokinin 1 Receptor Antagonist.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for Neurokinin 1 Receptor Antagonist: rolapitant, aprepitant, fosnetupitant palonosetron, netupitant palonosetron, fosaprepitant),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.) |
Resources that use this resource
No resources found
Resources that this resource uses
Narrative
No narrative content found in resource
Source1
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1116.602",
"meta": {
"versionId": "17",
"lastUpdated": "2024-07-03T01:06:58.000-04:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "American Society of Clinical Oncology Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-04-08"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2024-07-03"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.602",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1116.602"
}
],
"version": "20240703",
"name": "Neurokinin1ReceptorAntagonist",
"title": "Neurokinin 1 Receptor Antagonist",
"status": "active",
"date": "2024-07-03T01:06:58-04:00",
"publisher": "American Society of Clinical Oncology Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: The purpose of this value set is to represent concepts of medication for Neurokinin 1 Receptor Antagonist.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for Neurokinin 1 Receptor Antagonist: rolapitant, aprepitant, fosnetupitant palonosetron, netupitant palonosetron, fosaprepitant),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
"compose": {
"include": [
{
"valueSet": [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.222"
]
},
{
"valueSet": [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.145"
]
},
{
"valueSet": [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.147"
]
},
{
"valueSet": [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.144"
]
},
{
"valueSet": [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.146"
]
},
{
"valueSet": [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.560"
]
},
{
"valueSet": [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.223"
]
}
]
},
"expansion": {
"identifier": "urn:uuid:960fc6bc-3e91-449f-8b3e-d9be3a36f4a2",
"timestamp": "2025-05-23T18:19:31-04:00",
"total": 15,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1552343",
"display": "netupitant 300 MG / palonosetron 0.5 MG Oral Capsule"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1665503",
"display": "rolapitant 90 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1729308",
"display": "aprepitant 125 MG Powder for Oral Suspension"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1731075",
"display": "fosaprepitant 115 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1731077",
"display": "fosaprepitant 150 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1986885",
"display": "92.5 ML rolapitant 1.8 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1995150",
"display": "18 ML aprepitant 7.2 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2044429",
"display": "fosnetupitant 235 MG / palonosetron 0.25 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2374366",
"display": "20 ML fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2631783",
"display": "4.4 ML aprepitant 7.2 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2664065",
"display": "50 ML fosaprepitant 3 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "403810",
"display": "aprepitant 80 MG Oral Capsule"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "403811",
"display": "aprepitant 125 MG Oral Capsule"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "644088",
"display": "aprepitant 40 MG Oral Capsule"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "754508",
"display": "{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack"
}
]
}
}